Business news – Page 92
-
Business
Sabic invests $500m in new R&D centres
Four centres to be created: two in Saudi Arabia, one in India and one in China
-
Opinion
Name reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
-
Business
OM Group to exit cobalt business
Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
-
Business
Vasella to leave Novartis in August
Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
India pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
UK companies struggling with Reach
Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Dow Corning to reduce roster by 500
Company says it must respond to oversupplied markets, high raw materials costs and poor growth in many regions
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
-
Business
Wellcome Trust launches investment wing
Trust provides £200 million to create Syncona, which will support innovative healthcare businesses
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business
Clariant sells business bundle for CHF500m
Textile, paper and emulsion businesses to go to US investment firm
-
Business
2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Opinion
Fear of the unknown
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe